Drug Profile
Natural killer cell therapy - Tella/ Kyushu University
Alternative Names: ZNK cell therapy - TellaLatest Information Update: 10 Oct 2021
Price :
$50
*
At a glance
- Originator Kyushu University; Tella
- Class Immunotherapies; Natural killer cell therapies
- Mechanism of Action Natural killer cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for preclinical development in Cancer in Japan (Parenteral)